These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22349672)

  • 1. Effects of inhaled iloprost on congenital heart disease with Eisenmenger syndrome.
    Yang SI; Chung WJ; Jung SH; Choi DY
    Pediatr Cardiol; 2012 Jun; 33(5):744-8. PubMed ID: 22349672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study).
    Cha KS; Cho KI; Seo JS; Choi JH; Park YH; Yang DH; Hong GR; Kim DS
    Am J Cardiol; 2013 Dec; 112(11):1834-9. PubMed ID: 24012036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome.
    Chon MK; Cho KI; Cha KS; Seo JS; Kim DS
    J Cardiol; 2017 May; 69(5):741-746. PubMed ID: 27492657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study.
    Nashat H; Kempny A; Harries C; Dormand N; Alonso-Gonzalez R; Price LC; Gatzoulis MA; Dimopoulos K; Wort SJ
    Int J Cardiol; 2020 Jan; 299():131-135. PubMed ID: 31371115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.
    Agapito AF; Sousa L; Oliveira JA; Feliciano J; Cacela D; Quininha J
    Rev Port Cardiol; 2005 Mar; 24(3):421-31. PubMed ID: 15929625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of long-term combined therapy with inhaled iloprost and oral sildenafil in an adult patient with eisenmenger syndrome.
    Okyay K; Cemri M; Boyac B; Yalcn R; Cengel A
    Cardiol Rev; 2005; 13(6):312-4. PubMed ID: 16230890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
    J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.
    Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC
    Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.
    Tay EL; Papaphylactou M; Diller GP; Alonso-Gonzalez R; Inuzuka R; Giannakoulas G; Harries C; Wort SJ; Swan L; Dimopoulos K; Gatzoulis MA
    Int J Cardiol; 2011 Jun; 149(3):372-6. PubMed ID: 20304507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
    Olschewski H; Ghofrani HA; Schmehl T; Winkler J; Wilkens H; Höper MM; Behr J; Kleber FX; Seeger W
    Ann Intern Med; 2000 Mar; 132(6):435-43. PubMed ID: 10733442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled iloprost for severe pulmonary hypertension.
    Olschewski H; Simonneau G; Galiè N; Higenbottam T; Naeije R; Rubin LJ; Nikkho S; Speich R; Hoeper MM; Behr J; Winkler J; Sitbon O; Popov W; Ghofrani HA; Manes A; Kiely DG; Ewert R; Meyer A; Corris PA; Delcroix M; Gomez-Sanchez M; Siedentop H; Seeger W;
    N Engl J Med; 2002 Aug; 347(5):322-9. PubMed ID: 12151469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
    Gatzoulis MA; Landzberg M; Beghetti M; Berger RM; Efficace M; Gesang S; He J; Papadakis K; Pulido T; Galiè N;
    Circulation; 2019 Jan; 139(1):51-63. PubMed ID: 30586694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
    Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
    Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.
    Ivy DD; Doran AK; Smith KJ; Mallory GB; Beghetti M; Barst RJ; Brady D; Law Y; Parker D; Claussen L; Abman SH
    J Am Coll Cardiol; 2008 Jan; 51(2):161-9. PubMed ID: 18191742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.
    Hoeper MM; Spiekerkoetter E; Westerkamp V; Gatzke R; Fabel H
    Eur Respir J; 2002 Aug; 20(2):339-43. PubMed ID: 12212965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.
    Mukhopadhyay S; Sharma M; Ramakrishnan S; Yusuf J; Gupta MD; Bhamri N; Trehan V; Tyagi S
    Circulation; 2006 Oct; 114(17):1807-10. PubMed ID: 17030688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
    Bourge RC; Tapson VF; Safdar Z; Benza RL; Channick RN; Rosenzweig EB; Shapiro S; White RJ; McSwain CS; Gotzkowsky SK; Nelsen AC; Rubin LJ
    Cardiovasc Ther; 2013 Feb; 31(1):38-44. PubMed ID: 22970909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome.
    Kempny A; Dimopoulos K; Alonso-Gonzalez R; Alvarez-Barredo M; Tutarel O; Uebing A; Piatek P; Marino P; Swan L; Diller GP; Wort SJ; Gatzoulis MA
    Int J Cardiol; 2013 Oct; 168(5):4784-9. PubMed ID: 23962785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.